{"DataElement":{"publicId":"3104061","version":"2","preferredName":"Residual Disease Post New Tumor Event Margin Status","preferredDefinition":"Text term to describe the status of tissue margins following surgical resection for a locoregional procedure.","longName":"3104059v1.0:2608700v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3104059","version":"1","preferredName":"Residual Disease Post New Neoplasm Status","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made._Post; occuring after._New; having no previous example or precedent or parallel._(TOO-mer) An abnormal mass of tissue that results from excessive cell division. Tumors perform no useful body function. They may be benign (not cancerous) or malignant (cancerous)._A condition or state at a particular time.","longName":"2239882v1.0:3104057v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2239882","version":"1","preferredName":"Residual Disease","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made.","longName":"C4809","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8295-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-24","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-24","modifiedBy":"ONEDATA","dateModified":"2005-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3104057","version":"1","preferredName":"Post New Neoplasm Status","preferredDefinition":"Post; occuring after.:New; having no previous example or precedent or parallel.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:A condition or state at a particular time.","longName":"C38008:C25586:C3262:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87D85511-0C1E-E4AE-E040-BB89AD4308C6","latestVersionIndicator":"Yes","beginDate":"2010-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-30","modifiedBy":"ONEDATA","dateModified":"2010-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87D85511-0C2F-E4AE-E040-BB89AD4308C6","latestVersionIndicator":"Yes","beginDate":"2010-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2608700","version":"1.1","preferredName":"Margin Status","preferredDefinition":"Text terms to describe the status of a tissue margin.","longName":"MARG_STAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No source documentation","valueDescription":"No/Not in source document","ValueMeaning":{"publicId":"2604857","version":"1","preferredName":"No/Not in source document","longName":"2604857","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AB6C02E-D628-0591-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DA7-705E-E053-F662850A7943","beginDate":"2007-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"R0","valueDescription":"All Margins Pathologically Negative","ValueMeaning":{"publicId":"2558208","version":"1","preferredName":"All Margins Pathologically Negative","longName":"2558208","preferredDefinition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Surgical Margin","conceptCode":"C48621","definition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B06D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DB1-705E-E053-F662850A7943","beginDate":"2004-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"R1","valueDescription":"Microscopically Positive Margins or Microscopic Residual Disease","ValueMeaning":{"publicId":"2559219","version":"1","preferredName":"Microscopically Positive Margins or Microscopic Residual Disease","longName":"2559219","preferredDefinition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.: A finding resulting from the examination of a tissue sample under light or electron microscopy.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Surgical Margin","conceptCode":"C48620","definition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histopathology Result","conceptCode":"C83490","definition":"A finding resulting from the examination of a tissue sample under light or electron microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B460-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DBB-705E-E053-F662850A7943","beginDate":"2004-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"R2","valueDescription":"Macroscopically Positive Margins or Gross Residual Disease","ValueMeaning":{"publicId":"2559141","version":"1","preferredName":"Macroscopically Positive Margins or Gross Residual Disease","longName":"2559141","preferredDefinition":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen.: Visible to the naked eye.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Macroscopically Positive Surgical Margin","conceptCode":"C120274","definition":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gross","conceptCode":"C43566","definition":"Visible to the naked eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B412-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DC5-705E-E053-F662850A7943","beginDate":"2004-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"RX","valueDescription":"Presence of Residual Disease Cannot Be Assessed","ValueMeaning":{"publicId":"2559858","version":"1","preferredName":"Presence of Residual Disease Cannot Be Assessed","longName":"2559858","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made.: Being or existing in a specified place or at the specified time.: Aspects of the context prevent the evaluation needed to determine a value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6DF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DCF-705E-E053-F662850A7943","beginDate":"2002-02-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"Not evaluated","valueDescription":"Not Evaluated","ValueMeaning":{"publicId":"5607983","version":"1","preferredName":"Not Evaluated","longName":"5607983","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4408282D-3DE1-705E-E053-F662850A7943","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DFA-705E-E053-F662850A7943","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2608699","version":"1","preferredName":"Margin Status","preferredDefinition":"Margin; the boundary line or the area immediately inside the boundary.:A condition or state at a particular time.","longName":"C25563:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin","conceptCode":"C25563","definition":"A boundary line or the area immediately inside the boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B1E2B8A-8DB4-37B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-07","modifiedBy":"ONEDATA","dateModified":"2007-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4408282D-3D90-705E-E053-F662850A7943","latestVersionIndicator":"Yes","beginDate":"2007-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","changeDescription":"Versioned to extend max length and add PV as requested by K.Wildermuth. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Residual tumor after surgery","type":"Preferred Question Text","description":"Residual tumor after surgery for a new  tumor event (locoregional)","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4409E3A0-32C0-18BA-E053-F662850AAF4D","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"TSESU","dateModified":"2018-07-10","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of G. Diaz 5/2010. Versioned to extend max length and add PV as requested by K.Wildermuth. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}